Table 2.
Univariate analysis |
Multivariate analysis |
|||||
---|---|---|---|---|---|---|
HR | 95% CI | P⁎ | HR | 95% CI | P⁎⁎ | |
TRIM24 | ||||||
≤25 | 1 | 0.025 | 1 | 0.003 | ||
>25 | 5.0 | (1.1; 23.3) | 8.1 | (1.6; 41.8) | ||
N | ||||||
N0 | 1 | 0.189 | ||||
N+ | 2.35 | (0.6; 8.7) | ||||
ER | ||||||
ER− | 1 | 0.019 | 1 | 0.004 | ||
ER+ | 0.28 | (0.09; 0.9) | 0.18 | (0.05; 0.6) | ||
PR | ||||||
PR− | 1 | 0.034 | ||||
PR+ | 0.22 | (0.05; 1.01) | ||||
p53 | ||||||
WT | 1 | 0.245 | ||||
Mut | 1.90 | (0.6; 5.7) | ||||
Grade SBR | ||||||
I | 1 | 0.041 | ||||
II | 2.88 | (0.3; 24.6) | ||||
III | 9.54 | (0.9; 92.8) |
ER, Estrogen Receptor; PR, Progesterone Receptor; SBR, Scarff-Bloom-Richardson.
Logrank test.
Likelihood-ratio test.